Philipp Erben
Impact in
- Hematology top 0.2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 54
- Chronic Myeloid Leukemia Treatments 52
- Surgery 52
- Bladder and Urothelial Cancer Treatments 46
- Urinary and Genital Oncology Studies 22
- Co-authors
- Andreas Hochhaus (66 shared papers)Martin C. Müller (20 shared papers)Thomas Ernst (22 shared papers)Susan Branford (9 shared papers)Jörge E. Cortes (6 shared papers)Giuseppe Saglio (11 shared papers)Dong‐Wook Kim (7 shared papers)Nicholas C.P. Cross (16 shared papers)
- Journals
- Blood (28 papers)Journal of Clinical Oncology (10 papers)Haematologica (7 papers)Journal of Cancer Research and Clinical Oncology (6 papers)Leukemia (6 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Philipp Erben
159 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 90
- Hematology 2.0k
- Genetics 1.5k
- Rheumatology 1.3k
- Cancer Research 308
- Oncology 522
Countries citing papers authored by Philipp Erben
This map shows the geographic impact of Philipp Erben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Erben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Erben more than expected).
Fields of papers citing papers by Philipp Erben
This network shows the impact of papers produced by Philipp Erben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Erben. The network helps show where Philipp Erben may publish in the future.
Co-authors
The 25 scholars most cited alongside Philipp Erben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 309 | |
| 2 | 2009 | 243 | |
| 3 | 2009 | 227 | |
| 4 | 2009 | 155 | |
| 5 | 2009 | 145 | |
| 6 | 2010 | 124 | |
| 7 | 2006 | 119 | |
| 8 | 2010 | 99 | |
| 9 | 2008 | 88 | |
| 10 | 2013 | 88 | |
| 11 | 2008 | 88 | |
| 12 | 2009 | 81 | |
| 13 | 2007 | 70 | |
| 14 | 2011 | 68 | |
| 15 | 2007 | 67 | |
| 16 | 2007 | 65 | |
| 17 | 2006 | 59 | |
| 18 | 2011 | 58 | |
| 19 | 2019 | 58 | |
| 20 | 2009 | 57 |
About Philipp Erben
Philipp Erben is a scholar working on Hematology, Surgery, Genetics, Rheumatology and Molecular Biology, having authored 161 papers that have together received 3.9k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (52 papers), Bladder and Urothelial Cancer Treatments (46 papers), Eosinophilic Disorders and Syndromes (40 papers), Chronic Lymphocytic Leukemia Research (33 papers), Urinary and Genital Oncology Studies (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Ferroptosis and cancer prognosis (7 papers). The work is most often cited by research in Hematology (2.0k citations), Genetics (1.5k citations), Rheumatology (1.3k citations), Cancer Research (308 citations) and Oncology (522 citations). Philipp Erben has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Andreas Hochhaus, Martin C. Müller, Thomas Ernst, Susan Branford, Jörge E. Cortes, Giuseppe Saglio, Dong‐Wook Kim, Nicholas C.P. Cross, Rüdiger Hehlmann and Andreas Reiter. Their work appears in journals such as Blood, Journal of Clinical Oncology, Haematologica, Journal of Cancer Research and Clinical Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.